Technetium 99m may now be used to identify sentinel nodes for surgical excision in a growing number of cancer sites. The pathology specimens of these sentinel nodes and of any injected tumoural sites are radioactive. Consequently, specific clinical and laboratory procedures must be developed to handle these specimens safely. It is recommended that specimens containing the injection site should be quarantined for a period to permit decay of radioactivity. This quarantine does delay the reporting of pathology results to surgeons, oncologists and other clinicians, but it does not adversely affect final patient management.
Notes
Cites: Ann Surg Oncol. 1999 Jan-Feb;6(1):10-110030407
Cites: Ann Surg Oncol. 1999 Jan-Feb;6(1):75-8210030418
Cites: Am J Surg Pathol. 1999 Jun;23(6):686-9010366151
Cites: Lancet. 1999 Jun 5;353(9168):1937-810371577
Cites: Lancet. 1999 Aug 14;354(9178):57010470709
Cites: Ann Surg. 1995 Sep;222(3):394-9; discussion 399-4017677468
Cites: Can J Surg. 1999 Dec;42(6):406-710593235
Cites: Cancer. 2000 Mar 1;88(5):971-710699882
Cites: Cancer. 2000 Mar 1;88(5):1099-10710699901
Cites: Cancer. 2000 Jun 1;88(11):2540-510861431
Cites: Am J Surg Pathol. 2000 Nov;24(11):1549-5111075858
Cites: Am J Surg Pathol. 1999 Oct;23(10):1169-7210524517